US 9675588
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
granted A61KA61K31/4178A61K9/2013
Quick answer
US patent 9675588 (Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms) held by RedHill Biopharma Ltd. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4178, A61K9/2013, A61K9/2054, A61K9/2077